[[A]D401-3vn] 17. Biofunctional Chemistry, Biotechnology

4:55 PM - 5:05 PM JST(7:55 AM - 8:05 AM UTC)English

[[A]D401-3vn-07] Development of Chimeric Artificial Nucleic Acids (CANA) Toward the COVID-19 Treatments V: Effects of junction positions and complex stabilities on cleavage efficiencies

○Hieu Trong Bui¹, Kazutoshi Fujita¹, Nozomu Ishiwata¹, Masahito Inagaki², Hironori Hayashi¹, Mitsuyo Matsumoto¹, Yasuyuki Araki¹, Eiichi Kodama¹, Takehiko Wada¹ (1. Tohoku University, 2. Nagoya University)

Keywords:

Oligonucleotide therapeutics,COVID-19,Catalytic cleavage,RNase H,Chimeric Artificial Nucleic Acids